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Uruguay1. Introduction
More than a decade ago, Uruguay developed the Health Initiatives
against Unsafe Abortion program. Its underlying goal was to include
women with an unwanted pregnancy in the health system by applying
the risk and harm reduction policy. This model’s theoretical develop-
ment, and its initial deployment, took place in the university services
operating in the Pereira Rossell Hospital, Montevideo, Uruguay. This
hospital is the leading tertiary center for women’s health care in
Uruguay and the leading center for training in human health resources
associated with sexual and reproductive health.
The prestige of this hospital and the inﬂuence of their leaders among
the medical community and governmental authorities enabled the
model to be rolled out to the entire country, giving rise to one of the
greatest advances in public policies addressing sexual and reproductive
health, which led to a rapid decrease in abortion-related maternal mor-
tality in Uruguay [1].
The dissemination of the model, with its rapid positive effect on
women’s health, smoothed the way for the debate that led to the ap-
proval of an important legal reform that liberalized voluntary abortion
in Uruguay, embodied in the Voluntary Termination of Pregnancy
(VTP) Law 18.987, which was approved in October 2012 [2].Uruguay. Tel.: +598 27099122.
.
ology and Obstetrics. Published byAs expected, there was a lengthy, far-ranging debate prior to the
approval of this law, with strong opposition from groups that argued
that if abortion was decriminalized, women would neglect use of con-
traceptive methods and engage in high-risk sexual behaviors because,
if they were to become pregnant, they could easily terminate it. This
argument assumes that women take abortion lightly and abort with-
out hesitation, while what has been observed in practice is actually
very different [3].
Accordingly, it is very important to disseminate the current evi-
dence, which shows that abortion rates are lower in countries with lib-
eral laws than in countrieswith restrictive laws. Indeed,when one looks
at what happened to the abortion rates in countries that liberalized
these laws, it is seen that the rates tend to fall rather than rise [4,5].
There is no doubt that the abortion rate basically depends on the popu-
lation having information and access to modern, effective methods for
avoiding an unintended pregnancy [6].
One possible explanation for this reduction in the abortion rate after
legalization is that by making abortion legal and part of ofﬁcial health
services, these services seek to avoid a repetition of the abortion, pro-
viding complete, accessible information about how to prevent another
pregnancy and immediately providing the woman with the contra-
ceptive method she has chosen. By reducing the number of repeat
abortions, total abortions also fall.
The Uruguayan Ministry of Public Health has published a proce-
dural manual for the health management of voluntary termination
of pregnancy, which deﬁnes the actions to be performed in a total ofElsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
Table 1
Age and gestational age of the women at the time of termination of pregnancy during the
period before and after legislative change.a
May 2007–July 2009 (before)
(n = 648)
August 2014–August 2015 (after)
(n = 375)
Age, y 26.5 (11–46) 31.3 (12–45)
Gestational age, wk 8.2 (5–23) 9.5 (5–14)
a Values are given as mean (range).
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termination. The fourth visit is when the woman receives postabortion
care [7].
This last visit is very important—not only to assure the procedure’s
efﬁcacy and safety, but also to put into effect measures to avoid another
unwanted pregnancy. The recommended actions include guidance and
counseling on future pregnancies, contraception, and access to sexual
and reproductive health services.
Evidence has shown that postabortion contraceptionmustmeet two
conditions to achieve maximum efﬁcacy in preventing recurrence of an
unwanted pregnancy and, possibly, a repeat abortion [8]. First, it must
be offered before the patient leaves the health facility where abortion
care was provided. Experience has shown that if the woman is not
given her contraceptive method before discharge, but instead she is re-
ferred to another service to obtain her method at a later time, the risks
of a further unplanned pregnancy and another abortion are signiﬁcantly
higher [9,10].
The second condition is that preferencemust be given to long-acting
reversible contraceptives (LARCs), which have been clearly shown to be
more effective than short-acting methods in preventing unintended
pregnancies and further abortions [11,12].
This repeat abortion prevention policy through postabortion con-
traception was applied at the Pereira Rossell Hospital’s Sexual and
Reproductive Health Service. The purpose of the present study is to
evaluate whether application of this strategy has had the expected
success to determine whether it is necessary to make changes to the
current procedures.
2. Materials and methods
This retrospective study used data from the contraceptive care ser-
vices provided at the Pereira Rossell Hospital’s Sexual and Reproductive
Health Service during the period before (May 2007–July 2009) and after
(August 2014–August 2015) decriminalization of abortion and imple-
mentation of VTP services.
During the ﬁrst period, womenwere treated in accordance with the
risk and harm reduction regulations in force at that time, receiving pre-
and postabortion care. During the second period, women were treated
in accordance with the decriminalized abortion regulations.
The data were collected using forms that had been designed to re-
cord the user’s data during the VTP process. General information was
obtained from the databases that were generated using the information
recorded on the VTP forms. Unfortunately, the quality of the records
during the transitional period from the risk and harm strategy to legal
abortion was poor and therefore two periods that were more distant
from the transitional phasewere evaluated, taking into account the lim-
itations that this implies.
The study population consisted of all users treated before, during,
and after the VTP process at the Pereira Rossell Hospital during the
deﬁned periods.
The age of the women and the gestational age at the time of
performing VTP, the contraceptive methods used before abortion,
and the methods accepted at the postabortion visit were analyzed
for each period. It was not possible to determine the statistical signif-
icance of the mean of the women’s age or the gestational age because
the information available did not include standard deviations; the
database is held at the Ministry of Health and we were not given
access to it to perform this analysis. The differences in the proportion
of women who came back to the postabortion visit and in the contra-
ceptive methods used in the periods before and after the legislation
change were assessed using the Yates χ2 test or Fisher exact test,
as applicable.
As this is a secondary data analysis in which the women’s identity
is not known, informed consent was not required. The project was
approved by the Department of Sexual and Reproductive Health of the
Ministry of Public Health and by the Pereira Rossell Hospital Center.3. Results
In the ﬁrst period, before liberalization of the abortion law, risk re-
duction counselingwas provided to 2511women; 648 (25.8%) received
care before and after abortion at that hospital. In the second period, a
total of 1137 women underwent a VTP at the Pereira Rossell Hospital;
375 (33.0%) returned for postabortion care. Thus, the study population
consisted of 648 women in the period before the legislative change
and 375women evaluated during the periodwith liberal abortion legis-
lation. A further complication is that no informationwas recorded about
the contraceptive method used before pregnancy in 3.2% (21 cases) in
the ﬁrst period and 13.6% (51 cases) in the second period. Likewise,
this information was missing with respect to the contraceptive method
used after abortion in 2.9% (19 cases) in the ﬁrst period and 12.5%
(47 cases) in the second period.
The percentage of women who were seen after abortion was signif-
icantly higher in the period after liberalization of the law than in the pe-
riod before liberalization (33.0% vs 25.8%; P b 0.001).
The women’s average age in the period after legalization of abortion
was 5 years older than in the period before legalization. Although
themeangestational agewasmore than aweek higher in the post legal-
ization period, the upper limit for gestational age was 23 weeks in
the earlier period compared with 14 weeks after liberalization of the
law (Table 1).
The before and after legalization groupswere very different in terms
of their use of contraceptive methods before abortion. In the second
period, 25% of the women did not use any method compared with just
3.5% in the ﬁrst period. Likewise, the percentage of women who used
short-acting methods was signiﬁcantly greater in the ﬁrst period than
in the second period (94.1% vs 62.0%; P b 0.001); however, use of the in-
trauterine device (IUD) was signiﬁcantly higher in the second period
compared with the ﬁrst (12.3 vs 2.4; P b 0.001), when more than 12%
of the women became pregnant after using an IUD (Table 2).
All of the women who returned for the postabortion visit in the sec-
ond period received a contraceptive method compared with 94.6% in
the ﬁrst period (P b 0.001) (Table 3). Furthermore, this method was
long-acting in 57.3% of women in the second period compared with
40.5% in the ﬁrst period (P b 0.001).
The only LARC used during the ﬁrst period was the IUD. During the
second period, subcutaneous implants were included among LARCs.
While implants were not used as a contraceptive method before VTP,
they represented 82% of LARCs used after abortion.
4. Discussion
Despite the limitations caused by the poor quality of the data and the
lack of basic information for identifying statistically signiﬁcant differ-
ences in the women’s age and gestational age, the data suggest that
these two groups have different characteristics. In the ﬁrst period, the
women were younger and had a higher proportion of pregnancies
with a gestational age of less than 10 weeks. Unfortunately, no data
were available on parity.
The second period had a high proportion of pregnancies among
women who did not use any method of contraception, which was rare
in the ﬁrst period. It is surprising that 12.3% of women used an IUD in
the second period. This could be explained by a higher proportion of
Table 2
Use of contraceptives before abortion during the period before and after legislative
change.a
May 2007–July 2009
(before) (n = 627)b
August 2014–August 2015
(after) (n = 324)c
P value
Non-user 22 (3.5) 83 (25.6) b0.001
Short-acting 590 (94.1) 201 (62.0) b0.001
Intrauterine device 15 (2.4) 40 (12.3) b0.001
Implants 0 0
Tubal ligation 0 0
Long-acting method 15 (2.4) 40 (12.3) b0.001
Any method 605 (96.5) 241 (74.3) b0.001
a Values are given as number (percentage).
b Information missing for 21 cases (3.2%).
c Information missing for 51 cases (13.6%).
Table 3
Use of contraceptives after abortion during the period before and after legislative changea.
May 2007–July
2009(before) (n = 629)b
August 2014–August
2015c (after) (n = 328)c
P value
Non-user 34 (5.4) 0
Short-acting 340 (54.1) 140 (42.7) b0.001
Intrauterine device 255 (40.5) 30 (9.1)
Implants 0 154 (47.0)
Tubal ligation 0 4 (1.2)
Long-acting method 255 (40.5) 188 (57.3) b0.001
Any method 595 (94.6) 328 (100) b0.001
a Values are given as number (percentage).
b Information missing for 19 cases (2.9%).
c Information missing for 47 cases (12.5%).
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rouswomen in the previous period, since it is known thatmany doctors
are reluctant to insert IUDs in women who have not yet given birth.
Unfortunately, the lack of data on parity does not allow us to verify
whether this hypothesis is valid.
Although there was a signiﬁcant increase in the proportion of
women coming back for the postabortion visit in the second period
(from 25% to 33%), the postabortion visit rate is still disappointing,
as barely 1 out of every 3 women returned to receive a contraceptive
method. Because of this, the high percentage of women who started
using a long-acting method after the visit (57.3%) is misleading. If we
consider all of the women who had a pregnancy termination, we can
verify that only 188 of 1137(16.5%) used long-acting methods, and it
is unlikely that a proportion of those who did not return or for whom
we have no data used such methods.
Themain reason for this low rate of use is non-fulﬁllment of the prin-
ciple that postabortion contraception is truly effective when thewoman
leaves the health facility where the VTP was carried out already using a
modern method and that, ideally, it is a long-acting contraceptive.
One signiﬁcant factor explaining this problem is that most of the
VTPs are carried out usingmedication,which prevents immediate inser-
tion of an IUD. It is known, however, that use of hormonal methods can
be initiated at the time of administration of misoprostol [13,14]. The
data show that this was not done and, after this study, the necessary
changes must be made to ensure that this procedure becomes a routine
part of postabortion care. The data showing that implants have been
well accepted by this population reinforce the convenience of offering
them at the time of VTP using medication. Moreover, in the case
of those women who prefer an IUD, they can receive, for example, a
monthly or three-monthly contraceptive injection before leaving the fa-
cility and an appointment to insert an IUD 15 days ormore after the VTP.
The study’smethodological limitations are obvious as discussed pre-
viously. However, despite these limitations the data evaluated have
enabled us to verify that this part of VTP care has been neglected and
is a long way from attaining the success expected from it. Despite
these defects, we believe that it is very important not to hide our failure,
which illustrates the need to evaluate everything that is planned, so
that we can correct those aspects where we have not achieved the
desired goal. In this case, the data show that we failed to protect most
of these women from a further unintended pregnancy and a possible
repeat abortion.
Facedwith these results, itwill be necessary to review all of the steps
of the VTP process to correct each of the problems that limit access to
postabortion contraception.We hope that in a relatively short time, we will be able to show that
we were able to correct the problems, both in service provision and in
data collection, and that we have been able to provide most of these
women with effective protection against an unplanned pregnancy,
thereby contributing to preserve their sexual and reproductive health,
which is our ﬁnal purpose.
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